{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:55:37Z","timestamp":1781650537563,"version":"3.54.5"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T00:00:00Z","timestamp":1776470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":59,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Science Fund Program for Distinguished Young Scholars of the National Natural Science Foundation of China","award":["No. 21HAA01903"],"award-info":[{"award-number":["No. 21HAA01903"]}]},{"name":"the General Program Natural Science Foundation of Guangdong Province","award":["No. 2024A1515013182"],"award-info":[{"award-number":["No. 2024A1515013182"]}]},{"name":"the Science and Technology Innovation Base Plan of Jiangxi Province-Key Laboratory of Jiangxi Province for Transfusion Medicine","award":["No. 2024SSY06171"],"award-info":[{"award-number":["No. 2024SSY06171"]}]},{"name":"the Shenzhen Science and Technology Plan Basic Research Project","award":["No. JCYJ20190809172403604"],"award-info":[{"award-number":["No. JCYJ20190809172403604"]}]},{"name":"the Sanming Project of Medicine in Shenzhen","award":["No. SZSM201911004"],"award-info":[{"award-number":["No. SZSM201911004"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 82102899, No. 82170137, No. 32100729, No. 82273179"],"award-info":[{"award-number":["No. 82102899, No. 82170137, No. 32100729, No. 82273179"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"DOI":"10.1186\/s13046-026-03713-7","type":"journal-article","created":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T01:37:48Z","timestamp":1776476268000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The PPTC7\/BNIP3\/NIX axis induces cGAS\/STING-mediated senescence and augments CAR-T efficacy by repressing tumor-intrinsic mitophagy"],"prefix":"10.1186","volume":"45","author":[{"given":"Kuai","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxin","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantian","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanbin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,18]]},"reference":[{"key":"3713_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16160-5","author":"E Zah","year":"2020","unstructured":"Zah E, Nam E, Bhuvan V, Tran U, Ji BY, Gosliner SB, et al. Systematically optimized BCMA\/CS1 bispecific CAR-T cells robustly control heterogeneous multiple myeloma. Nat Commun. 2020. https:\/\/doi.org\/10.1038\/s41467-020-16160-5.","journal-title":"Nat Commun"},{"key":"3713_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2025.107677","volume":"151","author":"R Danis","year":"2025","unstructured":"Danis R, Bujarski S, Yashar D, Del Dosso A, Moore J, Mettias S, et al. Outcomes of triple-class refractory multiple myeloma patients at a single clinic: a retrospective study. Leuk Res. 2025;151:107677.","journal-title":"Leuk Res"},{"key":"3713_CR3","doi-asserted-by":"publisher","first-page":"4543","DOI":"10.1182\/bloodadvances.2025016322","volume":"9","author":"X Zhang","year":"2025","unstructured":"Zhang X, Wang L, Yang J, Hu XN, Wang H, Zhang LN, et al. Efficacy and safety of BCMA nanobody CAR T-cell therapy in relapsed or refractory plasma cell myeloma. Blood Adv. 2025;9:4543\u201352.","journal-title":"Blood Adv"},{"key":"3713_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1101495","author":"X Zhang","year":"2023","unstructured":"Zhang X, Zhang H, Lan H, Wu J, Xiao Y. CAR-T cell therapy in multiple myeloma: current limitations and potential strategies. Front Immunol. 2023. https:\/\/doi.org\/10.3389\/fimmu.2023.1101495.","journal-title":"Front Immunol"},{"key":"3713_CR5","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1158\/2643-3230.BCD-20-0020","volume":"1","author":"C Fern\u00e1ndez de Larrea","year":"2020","unstructured":"Fern\u00e1ndez de Larrea C, Staehr M, Lopez AV, Ng KY, Chen Y, Godfrey WD, et al. Defining an optimal dual-targeted CAR T-cell therapy approach simultaneously targeting BCMA and GPRC5D to prevent BCMA escape\u2013driven relapse in multiple myeloma. Blood Cancer Discov. 2020;1:146\u201354.","journal-title":"Blood Cancer Discov"},{"key":"3713_CR6","doi-asserted-by":"publisher","first-page":"3375","DOI":"10.1016\/j.ymthe.2025.03.001","volume":"33","author":"S Yang","year":"2025","unstructured":"Yang S, Wang G, Chen J, Zhang W, Wu J, Liu W, et al. Myeloma cell-intrinsic ANXA1 elevation and T cell dysfunction contribute to BCMA-negative relapse after CAR-T therapy. Mol Ther. 2025;33:3375\u201391.","journal-title":"Mol Ther"},{"key":"3713_CR7","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adv6902","author":"R Zhang","year":"2025","unstructured":"Zhang R, Gao F, Li J, Jin J, Chen K, Chaudhuri S, et al. USP30 inhibition augments mitophagy to prevent T cell exhaustion. Sci Adv. 2025. https:\/\/doi.org\/10.1126\/sciadv.adv6902.","journal-title":"Sci Adv"},{"key":"3713_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2022.101835","volume":"298","author":"Y Kushnareva","year":"2022","unstructured":"Kushnareva Y, Moraes V, Suess J, Peters B, Newmeyer DD, Kuwana T. Disruption of mitochondrial quality control genes promotes caspase-resistant cell survival following apoptotic stimuli. J Biol Chem. 2022;298:101835.","journal-title":"J Biol Chem"},{"key":"3713_CR9","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-008718","volume":"12","author":"W Zhu","year":"2024","unstructured":"Zhu W, Rao J, Zhang L, Xue K, Li L, Li J, et al. OMA1 competitively binds to HSPA9 to promote mitophagy and activate the cGAS\u2013STING pathway to mediate GBM immune escape. J Immunother Cancer. 2024;12:e008718.","journal-title":"J Immunother Cancer"},{"key":"3713_CR10","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nature14156","volume":"520","author":"AP West","year":"2015","unstructured":"West AP, Khoury-Hanold W, Staron M, Tal MC, Pineda CM, Lang SM, et al. Mitochondrial DNA stress primes the antiviral innate immune response. Nature. 2015;520:553\u20137.","journal-title":"Nature"},{"key":"3713_CR11","doi-asserted-by":"publisher","DOI":"10.1172\/jci139333","author":"M Hu","year":"2021","unstructured":"Hu M, Zhou M, Bao X, Pan D, Jiao M, Liu X, et al. ATM inhibition enhances cancer immunotherapy by promoting mtDNA leakage and cGAS\/STING activation. J Clin Invest. 2021. https:\/\/doi.org\/10.1172\/jci139333.","journal-title":"J Clin Invest"},{"key":"3713_CR12","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/s41422-022-00766-z","volume":"33","author":"X-Q Xie","year":"2023","unstructured":"Xie X-Q, Yang Y, Wang Q, Liu H-F, Fang X-Y, Li C-L, et al. Targeting ATAD3A-PINK1-mitophagy axis overcomes chemoimmunotherapy resistance by redirecting PD-L1 to mitochondria. Cell Res. 2023;33:215\u201328.","journal-title":"Cell Res"},{"key":"3713_CR13","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.molcel.2023.11.038","volume":"84","author":"Y Sun","year":"2024","unstructured":"Sun Y, Cao Y, Wan H, Memetimin A, Cao Y, Li L, et al. A mitophagy sensor PPTC7 controls BNIP3 and NIX degradation to regulate mitochondrial mass. Mol Cell. 2024;84:327\u2013e3449.","journal-title":"Mol Cell"},{"key":"3713_CR14","doi-asserted-by":"publisher","first-page":"3324","DOI":"10.1038\/s44319-024-00181-y","volume":"25","author":"GT Nguyen-Dien","year":"2024","unstructured":"Nguyen-Dien GT, Townsend B, Kulkarni PG, Kozul K-L, Ooi SS, Eldershaw DN, et al. PPTC7 antagonizes mitophagy by promoting BNIP3 and NIX degradation via SCFFBXL4. EMBO Rep. 2024;25:3324\u201347.","journal-title":"EMBO Rep"},{"key":"3713_CR15","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-025-04104-1","author":"M Gu","year":"2025","unstructured":"Gu M, Chen W, Ding S, Lin Z, Qian L, Xiao W, et al. Deletion of gasdermin D promotes granulocytic myeloid-derived suppressor cell differentiation by decreased release of mitochondrial DNA to promote tumor escape. Cancer Immunol Immunother. 2025. https:\/\/doi.org\/10.1007\/s00262-025-04104-1.","journal-title":"Cancer Immunol Immunother"},{"key":"3713_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-47692-9","author":"U Uslu","year":"2024","unstructured":"Uslu U, Sun L, Castelli S, Finck AV, Assenmacher C-A, Young RM, et al. The STING agonist IMSA101 enhances chimeric antigen receptor T cell function by inducing IL-18 secretion. Nat Commun. 2024. https:\/\/doi.org\/10.1038\/s41467-024-47692-9.","journal-title":"Nat Commun"},{"key":"3713_CR17","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.168945","author":"H Liu","year":"2023","unstructured":"Liu H, Ghosh S, Vaidya T, Bammidi S, Huang C, Shang P, et al. Activated cGAS\/STING signaling elicits endothelial cell senescence in early diabetic retinopathy. JCI Insight. 2023. https:\/\/doi.org\/10.1172\/jci.insight.168945.","journal-title":"JCI Insight"},{"key":"3713_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-021-01168-1","author":"F Ji","year":"2021","unstructured":"Ji F, Zhang F, Zhang M, Long K, Xia M, Lu F, et al. Targeting the DNA damage response enhances CD70 CAR-T cell therapy for renal carcinoma by activating the cGAS-STING pathway. J Hematol Oncol. 2021. https:\/\/doi.org\/10.1186\/s13045-021-01168-1.","journal-title":"J Hematol Oncol"},{"key":"3713_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-23463-8","author":"C Zhang","year":"2022","unstructured":"Zhang C, Zeng C, Xiong S, Zhao Z, Wu G. A mitophagy-related gene signature associated with prognosis and immune microenvironment in colorectal cancer. Sci Rep. 2022. https:\/\/doi.org\/10.1038\/s41598-022-23463-8.","journal-title":"Sci Rep"},{"key":"3713_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-023-11371-7","author":"Y Jia","year":"2023","unstructured":"Jia Y, Liu R, Shi L, Feng Y, Zhang L, Guo N, et al. Integrative analysis of the prognostic value and immune microenvironment of mitophagy-related signature for multiple myeloma. BMC Cancer. 2023. https:\/\/doi.org\/10.1186\/s12885-023-11371-7.","journal-title":"BMC Cancer"},{"key":"3713_CR21","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1158\/2643-3230.BCD-21-0047","volume":"2","author":"A Gulla","year":"2021","unstructured":"Gulla A, Morelli E, Samur MK, Botta C, Hideshima T, Bianchi G, et al. Bortezomib Induces Anti\u2013Multiple Myeloma Immune Response Mediated by cGAS\/STING Pathway Activation. Blood Cancer Discov. 2021;2:468\u201383.","journal-title":"Blood Cancer Discov"},{"key":"3713_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-019-0713-x","author":"L Zhou","year":"2019","unstructured":"Zhou L, Zhang Y, Leng Y, Dai Y, Kmieciak M, Kramer L, et al. The IAP antagonist birinapant potentiates bortezomib anti-myeloma activity in vitro and in vivo. J Hematol Oncol. 2019. https:\/\/doi.org\/10.1186\/s13045-019-0713-x.","journal-title":"J Hematol Oncol"},{"key":"3713_CR23","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1158\/1078-0432.CCR-15-0489","volume":"22","author":"A Gull\u00e0","year":"2016","unstructured":"Gull\u00e0 A, Di Martino MT, Gallo Cantafio ME, Morelli E, Amodio N, Botta C, et al. A 13 mer LNA-i-miR-221 Inhibitor Restores Drug Sensitivity in Melphalan-Refractory Multiple Myeloma Cells. Clin Cancer Res. 2016;22:1222\u201333.","journal-title":"Clin Cancer Res"},{"key":"3713_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01586-w","author":"L-X Zhang","year":"2022","unstructured":"Zhang L-X, Gao J, Long X, Zhang P-F, Yang X, Zhu S-Q, et al. The circular RNA circHMGB2 drives immunosuppression and anti-PD-1 resistance in lung adenocarcinomas and squamous cell carcinomas via the miR-181a-5p\/CARM1 axis. Mol Cancer. 2022. https:\/\/doi.org\/10.1186\/s12943-022-01586-w.","journal-title":"Mol Cancer"},{"key":"3713_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41389-024-00522-5","author":"M Gao","year":"2024","unstructured":"Gao M, Dong H, Jiang S, Chen F, Fu Y, Luo Y. Activated platelet-derived exosomal LRG1 promotes multiple myeloma cell growth. Oncogenesis. 2024. https:\/\/doi.org\/10.1038\/s41389-024-00522-5.","journal-title":"Oncogenesis"},{"key":"3713_CR26","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.548","author":"F Liu","year":"2021","unstructured":"Liu F, Wu Q, Han W, Laster K, Hu Y, Ma F, et al. Targeting integrin \u03b1v\u03b23 with indomethacin inhibits patient-derived xenograft tumour growth and recurrence in oesophageal squamous cell carcinoma. Clinical & Translational Med. 2021. https:\/\/doi.org\/10.1002\/ctm2.548.","journal-title":"Clinical & Translational Med"},{"key":"3713_CR27","doi-asserted-by":"publisher","first-page":"e008295","DOI":"10.1136\/jitc-2023-008295","volume":"12","author":"S Khoshtinat Nikkhoi","year":"2024","unstructured":"Khoshtinat Nikkhoi S, Yang G, Owji H, Grizotte-Lake M, Cohen RI, Gil Gonzalez L, et al. Bispecific immune cell engager enhances the anticancer activity of CD16\u2009+\u2009NK cells and macrophages in vitro, and eliminates cancer metastasis in NK humanized NOG mice. J Immunother Cancer. 2024;12:e008295.","journal-title":"J Immunother Cancer"},{"key":"3713_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-59818-8","author":"T Kimman","year":"2025","unstructured":"Kimman T, Cuenca M, Tieland RG, Rockx-Brouwer D, Janssen J, Motais B, et al. Engineering anti-BCMA CAR T cells for enhancing myeloma killing efficacy via apoptosis regulation. Nat Commun. 2025. https:\/\/doi.org\/10.1038\/s41467-025-59818-8.","journal-title":"Nat Commun"},{"key":"3713_CR29","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13622","author":"W Zhong","year":"2022","unstructured":"Zhong W, Rao Z, Xu J, Sun Y, Hu H, Wang P, et al. Defective mitophagy in aged macrophages promotes mitochondrial DNA cytosolic leakage to activate STING signaling during liver sterile inflammation. Aging Cell. 2022. https:\/\/doi.org\/10.1111\/acel.13622.","journal-title":"Aging Cell"},{"key":"3713_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06543-x","author":"N An","year":"2025","unstructured":"An N, Li J, Luo P, Wang D, Zhang P, Shu C, et al. Key predictors of long-term outcomes in BCMA-targeted CAR-T therapy for relapsed\/refractory multiple myeloma. J Transl Med. 2025. https:\/\/doi.org\/10.1186\/s12967-025-06543-x.","journal-title":"J Transl Med"},{"key":"3713_CR31","doi-asserted-by":"publisher","first-page":"3265","DOI":"10.1182\/blood-2024-208776","volume":"144","author":"K Lee","year":"2024","unstructured":"Lee K, Zhou Y, Franklin M, Ullman E, Hermann A, Kroog GS, et al. Characterization of Linvoseltamab\u2019s BCMA Binding Epitope and Efficacy Against BCMA Mutations in Relapsed\/Refractory Multiple Myeloma. Blood. 2024;144:3265\u20133265.","journal-title":"Blood"},{"key":"3713_CR32","doi-asserted-by":"publisher","first-page":"5794","DOI":"10.1182\/blood-2024-198117","volume":"144","author":"L Haertle","year":"2024","unstructured":"Haertle L, Buenache Cuenda N, Espejo Diaz I, L\u00e1zaro Del Campo P, Arroyo-Barea A, Rieger L, et al. Epigenetic Modifications As a Mechanism of Resistance to BCMA-Directed Immunotherapies in Multiple Myeloma: Insights from Multi-Omic Profiling. Blood. 2024;144:5794\u20135794.","journal-title":"Blood"},{"key":"3713_CR33","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2025.2529632","author":"A Oliver-Caldes","year":"2025","unstructured":"Oliver-Caldes A, Ma\u00f1e Pujol J, Battram AM, Perez-Amill L, Bachiller M, Calderon H, et al. Tigit blockade in the context of BCMA-CART cell therapy does not augment efficacy in a multiple myeloma mouse model. Oncoimmunology. 2025. https:\/\/doi.org\/10.1080\/2162402x.2025.2529632.","journal-title":"Oncoimmunology"},{"key":"3713_CR34","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1182\/blood-2024-201288","volume":"144","author":"F Maura","year":"2024","unstructured":"Maura F, Freeman CL, Lee H, Maclachlan KH, Durante M, Ziccheddu B, et al. Genomic Determinants of Resistance to Anti-BCMA Chimeric Antigen Receptor T-Cell (CART) Therapies in Patients with Relapsed\/Refractory Multiple Myeloma. Blood. 2024;144:247\u2013247.","journal-title":"Blood"},{"key":"3713_CR35","doi-asserted-by":"publisher","unstructured":"Ali M, Anjali, Mapa K. ANKZF1 helps to eliminate stress-damaged mitochondria by LC3-mediated mitophagy. Cell Death Discov. 2025;11. https:\/\/doi.org\/10.1038\/s41420-025-02638-y.","DOI":"10.1038\/s41420-025-02638-y"},{"key":"3713_CR36","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202503408","author":"L Hu","year":"2025","unstructured":"Hu L, Li J, Guo H, Su L, Dong P, Huang J, et al. Senp6 maintains mitochondrial homeostasis by regulating mitochondrial protein import through desumoylation of TOM40. Adv Sci. 2025. https:\/\/doi.org\/10.1002\/advs.202503408.","journal-title":"Adv Sci"},{"key":"3713_CR37","doi-asserted-by":"publisher","first-page":"3806","DOI":"10.1111\/cas.15913","volume":"114","author":"N Sasaki","year":"2023","unstructured":"Sasaki N, Homme M, Kitajima S. Targeting the loss of cGAS\/STING signaling in cancer. Cancer Sci. 2023;114:3806\u201315.","journal-title":"Cancer Sci"},{"key":"3713_CR38","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s41418-024-01280-y","volume":"31","author":"S Yamashita","year":"2024","unstructured":"Yamashita S, Sugiura Y, Matsuoka Y, Maeda R, Inoue K, Furukawa K, et al. Mitophagy mediated by BNIP3 and NIX protects against ferroptosis by downregulating mitochondrial reactive oxygen species. Cell Death Differ. 2024;31:651\u201361.","journal-title":"Cell Death Differ"},{"key":"3713_CR39","doi-asserted-by":"publisher","first-page":"e202402765","DOI":"10.26508\/lsa.202402765","volume":"7","author":"L Wei","year":"2024","unstructured":"Wei L, Gok MO, Svoboda JD, Kozul K-L, Forny M, Friedman JR, et al. Dual-localized PPTC7 limits mitophagy through proximal and dynamic interactions with BNIP3 and NIX. Life Sci Alliance. 2024;7:e202402765.","journal-title":"Life Sci Alliance"},{"key":"3713_CR40","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1038\/s41556-025-01712-y","volume":"27","author":"E Adriaenssens","year":"2025","unstructured":"Adriaenssens E, Schaar S, Cook ASI, Stuke JFM, Sawa-Makarska J, Nguyen TN, et al. Reconstitution of BNIP3\/NIX-mitophagy initiation reveals hierarchical flexibility of the autophagy machinery. Nat Cell Biol. 2025;27:1272\u201387.","journal-title":"Nat Cell Biol"},{"key":"3713_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1286942","author":"S Kerschbaum-Gruber","year":"2024","unstructured":"Kerschbaum-Gruber S, Kleinw\u00e4chter A, Popova K, Kneringer A, Appel L-M, Stasny K, et al. Cytosolic nucleic acid sensors and interferon beta-1 activation drive radiation-induced anti-tumour immune effects in human pancreatic cancer cells. Front Immunol. 2024. https:\/\/doi.org\/10.3389\/fimmu.2024.1286942.","journal-title":"Front Immunol"},{"key":"3713_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-025-03229-w","author":"X Hu","year":"2025","unstructured":"Hu X, Zhu H, Shen Y, Rao L, Li J, He X, et al. Metal-organic framework nanoparticles activate cGAS-STING pathway to improve radiotherapy sensitivity. J Nanobiotechnology. 2025. https:\/\/doi.org\/10.1186\/s12951-025-03229-w.","journal-title":"J Nanobiotechnology"}],"container-title":["Journal of Experimental & Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-026-03713-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-026-03713-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-026-03713-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:19:08Z","timestamp":1781648348000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13046-026-03713-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,18]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3713"],"URL":"https:\/\/doi.org\/10.1186\/s13046-026-03713-7","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,18]]},"assertion":[{"value":"20 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were conducted in strict compliance with relevant ethical guidelines and regulations. The study protocol was reviewed and approved by the Institutional Animal Care and Use Committee (IACUC) of The Sun Yat-sen University. Animals were housed under standard conditions with appropriate care, and every effort was made to minimize suffering. At the end of the experiments, all mice were humanely euthanized under ether anesthesia.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"135"}}